Aerami Therapeutics Holdings, Inc. of Durham, NC, a company, filed a Form D amendment with the SEC on 2019-06-11. The offering totals $59.2M, of which $21.0M was reported sold. Industry: Biotechnology.
Showing 25 of 45 people.
| Name | Role | Location |
|---|---|---|
| Matt S Jennings | Director | San Francisco, CA |
| John S Patton, Ph.D | Director | San Francisco, CA |
| Anne S Whitaker | Director | San Francisco, CA |
| Ben S Wolin | Director | San Francisco, CA |
| Mike K Kaseta | Executive Officer | San Francisco, CA |
| John S Patton, Ph.D | Executive Officer | San Francisco, CA |
| Dr. Melissa K Rhodes | Executive Officer | San Francisco, CA |
| Anne S Whitaker | Executive Officer | San Francisco, CA |
| Gary C Burgess | Executive Officer | Durham, NC |
| Anne C Whitaker | Director | Durham, NC |
| Anne C Whitaker | Executive Officer | Durham, NC |
| John S Patton | Director | Durham, NC |
| Steven C Thornton | Director | Durham, NC |
| William Patrick Welch | Director | Durham, NC |
| Joshua S Ziel | Executive Officer | Durham, NC |
| Darlene C Deptula-Hicks | Director | Durham, NC |
| Darlene C Deptula-Hicks | Executive Officer | Durham, NC |
| BILL K WELCH | Director | DEERFIELD, IL |
| STEVEN S THORNTON | Director | DEERFIELD, IL |
| STEVEN S THORNTON | Executive Officer | DEERFIELD, IL |
| DARLENE K DEPTULA-HICKS | Director | DEERFIELD, IL |
| BARRY K DEUTSCH | Executive Officer | DEERFIELD, IL |
| LISA K YANEZ | Executive Officer | DEERFIELD, IL |
| TIMM JEFFREY CROWDER | Executive Officer | DURHAM, NC |
| BILL S WELCH | Director | DURHAM, NC |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2023-11-22 | D | $20.0M | $1.0M |
| 2022-12-16 | D | $20.0M | $5.4M |
| 2021-11-04 | D/A | $22.3M | $22.3M |
| 2021-09-23 | D | $20.0M | $2.2M |
| 2020-06-17 | D | $15.0M | $4.6M |
| 2019-06-10 | D | $59.2M | $21.0M |
| 2018-01-11 | D/A | $36.7M | $19.0M |
| 2017-12-18 | D | $40.0M | $14.7M |
| 2017-06-26 | D/A | $5.0M | $3.4M |
| 2017-04-26 | D | $5.0M | $838K |
| 2016-08-04 | D | $23.0M | $625K |
| 2015-10-02 | D | $40.0M | $10.1M |